Skip Navigation LinksHome > August 2014 - Volume 59 - Issue 2 > Liver Disease in Autosomal Recessive Polycystic Kidney Disea...
Journal of Pediatric Gastroenterology & Nutrition:
doi: 10.1097/MPG.0000000000000422
Original Articles: Hepatology and Nutrition

Liver Disease in Autosomal Recessive Polycystic Kidney Disease: Clinical Characteristics and Management in Relation to Renal Failure

Luoto, Topi T.*; Pakarinen, Mikko P.*; Jahnukainen, Timo; Jalanko, Hannu

Collapse Box


Objectives: We correlated liver and kidney manifestations in a national cohort of patients with autosomal recessive polycystic kidney disease (ARPKD).

Methods: A total of 27 consecutive patients with ARPKD were included. Hepatobiliary disorders were comparatively evaluated in 2 groups: children in group 1 (n = 10) displayed renal failure as infants and those in group 2 (n = 17) had normal kidney function through the first year of life.

Results: Median follow-up time was 10.6 (range, 0.4–40) years. Portal hypertension was diagnosed in 13 patients (48%) at the median age 5.0 (1.5–27.9) years. Esophageal varices developed in 8 patients (30%) at age 8.0 (2.1–11.9) years; 4 patients (15%) had variceal bleeding, and hypersplenism/splenomegaly occurred in 52%, similarly in both groups. Biliary tract dilatation was detected at 2.8 years in group 1 and at 7.9 years in group 2, significantly more frequently in group 1 (60% vs 18%, P = 0.039), causing cholangitis in 2 (20%) versus none in group 2 (P = 0.055). A total of 10 patients (37%) underwent cadaveric liver transplantation (LT) at a median age of 6.6 (1.0–20.0) years. In 1 patient LT was performed because of hepatoblastoma. Nine of these were combined liver–kidney transplantations (CLKT). Patients in group 1 required LT earlier (4.1 years vs 18.2 years, P = 0.017) and more frequently (70% vs 18%, P = 0.01). Overall survival beyond neonatal period was 85%. Two patients died because of infectious complications after CLKT, and 1 patient because of recurrent hepatoblastoma.

Conclusions: Although correlation of renal and liver manifestations was variable, biliary dilatation was associated with early renal failure. CLKT may be a treatment for patients with ARPKD with marked hepatobiliary complications.

© 2014 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology,


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us